National Health Service
The Biomedical Catalyst fund has up to 10 million to invest in innovative projects that tackle some of the biggest healthcare challenges in the world.
Better and more efficient
A growing and ageing population is creating a need for better, more efficient health services.
The fund is a partnership between Innovate UK and the Medical Research Council. It aims to support innovative ideas across the life sciences sector, to make ideas from research and academia a reality.
Support is available across disciplines
Funding support is available in any sector or discipline including:
- stratified healthcare
- advanced therapies, such as gene and cell therapies
- medical technologies and devices
Projects should develop innovative healthcare products, technologies and processes. This could include projects that aim to:
- prevent disease or manage chronic health conditions
- detect or diagnose disease earlier
- provide tailored treatments that change the underlying disease or offer cures
There are 2 funding competitions being run. These are for:
- feasibility studies to explore and evaluate the commercial potential of early-stage ideas. Up to 2 million is available
- early-stage projects to create sufficient data to support later testing of products in a clinical or other relevant setting. Up to 8 million is available
- the competitions open on 26 March 2018, and the deadline for applications is 6 June 2018
- projects must be led by an SME, either working alone or with other SMEs or research organisations
- we expect feasibility projects to have total costs of up to 200,000 and to last between 3 and 12 months
- we expect early stage projects to have total costs of between 250,000 and 4 million and to last between 12 and 36 months
- businesses could attract up to 70% of their project costs
- a briefing event will be held on 4 April 2018